FN1 and endometrial cancer: investigated that SPARC activates fibroblasts only in the presence of fibronectin, which is abundantly secreted in endometrial cancer cells expressing SPARC, and SPARC-FN1-mediated fibroblast activation may be associated with increased cancer cell migration and invasiveness (35).